These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20158094)

  • 21. [PPARgamma agonists for the diseases of gastrointestinal tract and liver].
    Shimada T; Hiraishi H
    Nihon Rinsho; 2010 Feb; 68(2):312-6. PubMed ID: 20158102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components.
    Martin H
    Mutat Res; 2009 Oct; 669(1-2):1-7. PubMed ID: 19563816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective effects of KR-62980, a new PPARγ agonist, against chemical ischemia-reperfusion in SK-N-SH cells.
    Kim KY; Cho HS; Lee SH; Ahn JH; Cheon HG
    Brain Res; 2011 Feb; 1372():103-14. PubMed ID: 21111719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response.
    Malur A; Mccoy AJ; Arce S; Barna BP; Kavuru MS; Malur AG; Thomassen MJ
    J Immunol; 2009 May; 182(9):5816-22. PubMed ID: 19380830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and gene expression studies implicate renin and endothelin-1 in edema caused by peroxisome proliferator-activated receptor gamma agonists.
    Geese WJ; Achanzar W; Rubin C; Hariharan N; Cheng P; Tomlinson L; Ordway N; Dracopoli NC; Delmonte T; Hui L; Krishnan B; Cosma G; Ranade K
    Pharmacogenet Genomics; 2008 Oct; 18(10):903-10. PubMed ID: 18794727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
    Grommes C; Landreth GE; Sastre M; Beck M; Feinstein DL; Jacobs AH; Schlegel U; Heneka MT
    Mol Pharmacol; 2006 Nov; 70(5):1524-33. PubMed ID: 16887936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. THE PPARgamma ligand 15d-PGJ2 modulates macrophage activation after injury in a murine trauma model.
    Monroy MA; Opperman KK; Pucciarelli M; Yerrum S; Berg DA; Daly JM
    Shock; 2007 Aug; 28(2):186-91. PubMed ID: 17510607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacy.
    Keil S; Matter H; Schönafinger K; Glien M; Mathieu M; Marquette JP; Michot N; Haag-Diergarten S; Urmann M; Wendler W
    ChemMedChem; 2011 Apr; 6(4):633-53. PubMed ID: 21400663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced VDUP-1 gene expression by PPARgamma agonist induces apoptosis in human macrophage.
    Billiet L; Furman C; Larigauderie G; Copin C; Page S; Fruchart JC; Brand K; Rouis M
    J Cell Physiol; 2008 Jan; 214(1):183-91. PubMed ID: 17579352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptor gamma (PPARgamma): Is the genomic activity the only answer?
    Luconi M; Cantini G; Serio M
    Steroids; 2010; 75(8-9):585-94. PubMed ID: 19900469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PPARgamma antagonists exacerbate neural antigen-specific Th1 response and experimental allergic encephalomyelitis.
    Raikwar HP; Muthian G; Rajasingh J; Johnson C; Bright JJ
    J Neuroimmunol; 2005 Oct; 167(1-2):99-107. PubMed ID: 16091293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disorders.
    Heneka MT; Landreth GE; Hüll M
    Nat Clin Pract Neurol; 2007 Sep; 3(9):496-504. PubMed ID: 17805244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma.
    Oliveira AC; Bertollo CM; Rocha LT; Nascimento EB; Costa KA; Coelho MM
    Eur J Pharmacol; 2007 Apr; 561(1-3):194-201. PubMed ID: 17343847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor α and γ agonists together with TGF-β convert human CD4+CD25- T cells into functional Foxp3+ regulatory T cells.
    Lei J; Hasegawa H; Matsumoto T; Yasukawa M
    J Immunol; 2010 Dec; 185(12):7186-98. PubMed ID: 21057085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of peroxisome proliferation-activated receptor gamma expression by gamma-irradiation as a mechanism contributing to inflammatory response in rat colon: modulation by the 5-aminosalicylic acid agonist.
    Linard C; Grémy O; Benderitter M
    J Pharmacol Exp Ther; 2008 Mar; 324(3):911-20. PubMed ID: 18077625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of anti-inflammatory effects of PPARgamma agonists?
    Rogler G
    Gut; 2006 Aug; 55(8):1067-9. PubMed ID: 16849341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PPAR
    Reddy AT; Lakshmi SP; Reddy RC
    PPAR Res; 2016; 2016():7963540. PubMed ID: 27774097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiological Roles of PPARgamma in Gastrointestinal Epithelial Cells.
    Necela BM; Thompson EA
    PPAR Res; 2008; 2008():148687. PubMed ID: 18615192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The research progress of PPARγ in the Neurodegenerative disease].
    Guo P; Wang XM; Wang DS
    Sheng Li Ke Xue Jin Zhan; 2015 Oct; 46(5):379-82. PubMed ID: 26904863
    [No Abstract]   [Full Text] [Related]  

  • 40. [Regulation of allergic immune response of PPARgamma agonists--emerging roles in allergic response].
    Chihara J; Takeda M; Ueki S
    Nihon Rinsho; 2010 Feb; 68(2):261-5. PubMed ID: 20158094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.